Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$15,700,540
+$2,281,096 QoQ
Shares Held
13,090
-10.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#1,014
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOCKHEED MARTIN INVESTMENT MANAGEMENT CO holds $85,820,334 across 7 Drug Manufacturers - General names. LLY ranks #2 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
171,210 | $43,482,203 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
13,090 | $15,700,540 | |
| 3 | ABBV |
AbbVie Inc.
|
41,130 | $10,349,953 | |
| 4 | NVS |
Novartis AG
|
48,400 | $7,585,248 | |
| 5 | MRK |
Merck & Co., Inc.
|
32,500 | $4,176,250 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,100 | $3,044,794 | |
| 7 | NVO |
Novo Nordisk A S
|
30,900 | $1,481,346 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,700,540 | 13,090 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $13,419,444 | 14,590 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $12,982,135 | 12,080 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $8,980,510 | 11,770 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $30,534,190 | 39,170 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $15,997,876 | 19,370 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $17,979,880 | 23,290 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $14,866,073 | 16,780 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,263,450 | 2,500 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||